MEI.JO logo
JNB · MEI.JOMedical - Care FacilitiesUpdated Nov 4, 2026

Mediclinic International plc P/E ratio

Current valuation, historical context, and peer comparisons.

Current P/E ratio

2108.73×

8260.0% abovethe 4-observation annual average

Share price11,830
÷
Earnings per share5.61

Price and EPS in quote currency. Calculation details

Investors are paying 2108.73 for every 1 of reported earnings per share.

P/E over time

2016 – 2022
Annual P/ESelected-period average 25.22×
3-year average24.08×2 positive annual observations
5-year average24.08×2 positive annual observations
10-year average25.22×4 positive annual observations
Peer median · TTM21.80×5 peers with positive P/E

Historical P/E ratios

Annual period-end data · 7 observations

MEI.JO annual P/E history, newest first
Period endP/EChange
Mar 31, 202217.13×-44.8%
Mar 31, 202131.04×N/M
Mar 31, 2020N/MN/M
Mar 31, 2019N/MN/M
Mar 31, 2018N/MN/M
Mar 31, 201722.87×-23.4%
Mar 31, 201629.86×N/M

Change is relative to the preceding observation. N/M values are excluded from averages.

How MEI.JO compares

Company P/E vs. peer trailing-12-month ratios

P/E comparison with MEI.JO and provider-selected peers
CompanyP/E ratio
MEI.JO logo
MEI.JO This stockMediclinic International plc
2108.73×
APN.JO logo
APN.JOAspen Pharmacare Holdings Limited
27.92×
WHL.JO logo
WHL.JOWoolworths Holdings Limited
15.74×
REM.JO logo
REM.JORemgro Limited
80.70×
BTI.JO logo
BTI.JOBritish American Tobacco p.l.c.
15.64×
MTN.JO logo
MTN.JOMTN Group Limited
21.80×

Peers are selected by the data provider. Business models and earnings definitions can differ.

Put the numbers in context

What does MEI.JO’s P/E tell you?

01

Start with its own history

At 2108.73×, MEI.JO is 8260.0% above its 4-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

02

Compare like with like

The median of the 5 positive peer ratios above is 21.80×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.

03

Check what drives earnings

One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.

Keep your research connected

Take MEI.JO into your spreadsheet

Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.

Explore Wisesheets
Quarterly P/E · latest quarter
=WISE("MEI.JO", "PE Ratio", "LQ")
LQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data

Sources & calculation methodology

Current P/E

Share price 11,830 ÷ EPS 5.61 = 2108.73×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 4, 2026; this is not a real-time trading quote.

History & averages

Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.

Data definitions and limitations

The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.

MEI.JO P/E ratio: common questions

The essentials behind the numbers.

Mediclinic International plc's current P/E is 2108.73× based on the quote data last updated Nov 4, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.

Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.

N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.

Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.

Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.

Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.